Clinical Studies and LN FNA Core
Clinical Studies and LN FNA Core
批准号:
10580754
负责人:
Alessandro Sette
金额:
$16.38万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-11 至 2024-02-29
关键词:
AdherenceAdultAntigensAxillaB-LymphocytesBacteriaBiopsyBloodBlood donorBlood specimenCD4 Positive T LymphocytesCellsChildClinicalClinical ResearchCodeCollaborationsDengue VirusDiagnosisEnsureEpigenetic ProcessFine needle aspiration biopsyFoundationsGoalsHumanHuman Herpesvirus 4ImmunizationImmunizeIndividualInstitutional Review BoardsLungLymph Node TissueMaintenanceMalignant neoplasm of lungMediastinal lymph node groupOperative Surgical ProceduresPathologicPatientsPatternPediatric HospitalsPeripheral Blood Mononuclear CellPertussisPertussis VaccinePlasmaPreparationProceduresProtocols documentationQuality ControlRecurrenceResearch InstituteResectedResourcesRoleSamplingSampling StudiesSecondary toSiteSourceStreptococcus pyogenesStructure of parenchyma of lungT cell responseTissue SampleTissuesTonsilTonsillectomyTonsillitisTranslational ResearchVaccinatedVaccineeVaccinesVirusVirus DiseasesWorkYellow Fever VaccineYellow fever viruscohortcytotoxicdesigndraining lymph nodeexpectationinfancylymph node biopsylymph nodesminimally invasiveprogramsrecruitresearch studyresponseretention ratesuccesstumorultrasound
中文摘要
临床研究和LN FNA核心(核心B)
核心摘要
整个项目的成功取决于人体样本的成功采集。我们有信心
我们收集必要样本的能力将使最有力和最令人信服的研究成为可能。这个
临床研究和LN FNA核心将为人类淋巴结(LN)的积累提供集中资源,
肺、外周血单核细胞(PBMC)和血浆样本,并确保质量和一致性
对收到的样品的处理。这些功能对于为研究提供坚实的基础至关重要
三个拟议项目中所描述的。临床研究和LN FNA核心将与
个人项目、管理核心、测序和表观遗传学核心以及临床
分包商确保本计划建议书中所有目标的成功。这一核心将负责
编制和维护IRB方案,监督受试者招募,编码的质量控制
临床信息和捐献者样本。用于这项计划的队列包括来自油井的样本-
受人尊敬和成功的合作者和临床医生。我们将与加州大学圣迭戈分校的F.Hasteh博士和S.
加州大学洛杉矶分校的Yekezare(UCSD)和Altman临床与翻译研究所(ACTRI)
获取项目1、2和3的淋巴结细针抽吸物(LN FNA)样本。我们有一个长期的-
与M.T.Brigger博士(加州大学拉迪儿童分校)长期合作,获取扁桃体样本用于
项目1和项目3。我们还将与英国南安普敦的Ottensmeier博士合作,获取肺和肺-
为项目1和项目3抽干淋巴组织样本。LJI的内部临床核心将管理银行
来自项目2接种疫苗的个人的样本,并将提供所有新的百日咳和黄色样本
项目1、2和3需要接种发热病毒疫苗的捐赠者。
英文摘要
CLINICAL STUDIES AND LN FNA CORE (CORE B)
CORE SUMMARY
The success of the entire program is contingent upon successful accrual of human samples. We are confident
in our ability to amass the necessary samples that will enable the most robust and compelling studies. The
Clinical Studies and LN FNA Core will provide a centralized resource for accrual of human lymph node (LN),
lung, peripheral blood mononuclear cells (PBMC) and plasma samples, and ensure the quality and uniformity
of handling of the samples received. These functions are crucial to provide a strong foundation for the studies
described in the three proposed projects. The Clinical Studies and LN FNA Core will work closely with the
individual Projects, the Administrative Core, the Sequencing and Epigenetics Core, and the clinical
subcontractors to enable success of all objectives in this program proposal. This Core will be responsible for
the preparation and maintenance of IRB protocols, oversight of subject recruitment, quality control of coded
clinical information and donor samples. The cohorts to be used for this program include samples from well-
regarded and successful collaborators and clinicians. We will work closely with Drs. F. Hasteh (UCSD) and S.
Yekezare (UCSD) and the Altman Clinical and Translational Research Institute (ACTRI) at UCSD to enable
acquisition of lymph node fine needle aspirate (LN FNA) samples for Projects 1, 2 and 3. We have a long-
standing collaboration with Dr. M.T. Brigger (Rady Children's, UCSD) to obtain tonsil samples to be used for
Projects 1 and 3. We also will collaborate with Dr. Ottensmeier (Southampton, UK) to obtain lung and lung-
draining lymph node tissue samples for Projects 1 and 3. LJI's in-house Clinical Core will manage the banked
samples from vaccinated individuals for Project 2 and will provide all new samples from pertussis- and yellow
fever virus-vaccinated donors needed for Projects 1, 2 and 3.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
-
批准号:10265651
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2020
-
负责人:Alessandro Sette
-
依托单位:
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
-
批准号:10228367
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2020
-
负责人:Alessandro Sette
-
依托单位:
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
-
批准号:10056696
-
项目类别:
-
资助金额:$272.15万
-
财政年份:2020
-
负责人:Alessandro Sette
-
依托单位:
Large Scale T Cell Epitope Discovery: Global identification of epitopes derived from Zika (ZIKV) and Chikungunya (CHIKV) viruses following natural infection and vaccination
-
批准号:10020640
-
项目类别:
-
资助金额:$88.83万
-
财政年份:2019
-
负责人:Alessandro Sette
-
依托单位:
Large Scale T Cell Epitope Discovery: Genome-wide characterization of T cell epitopes from Bordetella pertussis in vaccination and natural infection
-
批准号:10616655
-
项目类别:
-
资助金额:$87.95万
-
财政年份:2019
-
负责人:Alessandro Sette
-
依托单位:
Large Scale T Cell Epitope Discovery: Genome-wide characterization of T cell epitopes from Bordetella pertussis in vaccination and natural infection
-
批准号:10439413
-
项目类别:
-
资助金额:$87.58万
-
财政年份:2019
-
负责人:Alessandro Sette
-
依托单位:
Clinical Studies and LN FNA Core
-
批准号:10371991
-
项目类别:
-
资助金额:$45.24万
-
财政年份:2019
-
负责人:Alessandro Sette
-
依托单位:
Mechanisms of differential responses to whole cell and acellular pertussis vaccination
-
批准号:10580758
-
项目类别:
-
资助金额:$73.15万
-
财政年份:2019
-
负责人:Alessandro Sette
-
依托单位:
Mechanisms of differential responses to whole cell and acellular pertussis vaccination
-
批准号:10366648
-
项目类别:
-
资助金额:$15.47万
-
财政年份:2019
-
负责人:Alessandro Sette
-
依托单位:
Mechanisms of differential responses to whole cell and acellular pertussis vaccination
-
批准号:10585309
-
项目类别:
-
资助金额:$80.82万
-
财政年份:2019
-
负责人:Alessandro Sette
-
依托单位:
Large Scale T Cell Epitope Discovery: Genome-wide characterization of T cell epitopes from Bordetella pertussis in vaccination and natural infection
-
批准号:10892738
-
项目类别:
-
资助金额:$88.41万
-
财政年份:2019
-
负责人:Alessandro Sette
-
依托单位:
Large Scale T Cell Epitope Discovery: Genome-wide characterization of T cell epitopes from Bordetella pertussis in vaccination and natural infection
-
批准号:10020648
-
项目类别:
-
资助金额:$91.88万
-
财政年份:2019
-
负责人:Alessandro Sette
-
依托单位:
Mechanisms of differential responses to whole cell and acellular pertussis vaccination
-
批准号:10374945
-
项目类别:
-
资助金额:$45.24万
-
财政年份:2019
-
负责人:Alessandro Sette
-
依托单位:
Administrative Core
-
批准号:10321620
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2018
-
负责人:Alessandro Sette
-
依托单位:
Autoimmune features of neurodegenerative disorders
-
批准号:9975948
-
项目类别:
-
资助金额:$83.95万
-
财政年份:2018
-
负责人:Alessandro Sette
-
依托单位:
Autoimmune features of neurodegenerative disorders
-
批准号:10214704
-
项目类别:
-
资助金额:$80.46万
-
财政年份:2018
-
负责人:Alessandro Sette
-
依托单位:
Cockroach and mouse allergy T cell phenotypes and their correlation with clinical status
-
批准号:10321623
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2018
-
负责人:Alessandro Sette
-
依托单位:
Autoimmune features of neurodegenerative disorders
-
批准号:10452771
-
项目类别:
-
资助金额:$77.62万
-
财政年份:2018
-
负责人:Alessandro Sette
-
依托单位:
LJI Epitope Validation Center: Characterization of epitope-specific T cells responding to food, fungal and inner city allergens
-
批准号:10321619
-
项目类别:
-
资助金额:$115.36万
-
财政年份:2018
-
负责人:Alessandro Sette
-
依托单位:
LJI Epitope Validation Center: Characterization of epitope-specific T cells responding to food, fungal and inner city allergens
-
批准号:10083696
-
项目类别:
-
资助金额:$127.92万
-
财政年份:2018
-
负责人:Alessandro Sette
-
依托单位:
海外基金